Cargando…
Use-case scenarios for an anti-Cryptosporidium therapeutic
Cryptosporidium is a widely distributed enteric parasite that has an increasingly appreciated pathogenic role, particularly in pediatric diarrhea. While cryptosporidiosis has likely affected humanity for millennia, its recent “emergence” is largely the result of discoveries made through major epidem...
Autores principales: | Ashigbie, Paul G., Shepherd, Susan, Steiner, Kevin L., Amadi, Beatrice, Aziz, Natasha, Manjunatha, Ujjini H., Spector, Jonathan M., Diagana, Thierry T., Kelly, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951839/ https://www.ncbi.nlm.nih.gov/pubmed/33705395 http://dx.doi.org/10.1371/journal.pntd.0009057 |
Ejemplares similares
-
Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing
Antiparasitic Agents
por: Jumani, Rajiv S., et al.
Publicado: (2021) -
Cryptosporidium: Still Open Scenarios
por: Pane, Stefania, et al.
Publicado: (2022) -
A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
por: Manjunatha, Ujjini H., et al.
Publicado: (2017) -
A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism
por: Manjunatha, Ujjini H., et al.
Publicado: (2005) -
An update on Cryptosporidium biology and therapeutic avenues
por: Dhal, Ajit Kumar, et al.
Publicado: (2022)